Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cat bacteria treats skin infection, study finds
The findings may have positive repercussions in new bacteriotherapies for humans and animals.
Researchers discovered a strand of cat bacteria that is resistant to eczema. 

Healthy cats have a bacteria that produces antibiotics against severe skin infections, a study from the University of California San Diego School of Medicine has found.

Published in eLife, the study, entitled 'Antimicrobials from a feline commensal bacterium inhibit skin infection by drug-resistant S. pseudintermedius' founds that bacteria on healthy cats could be used to treat a skin infection on mice. 

The infection, a bacterium known as Staphylococcus pseudintermedius (MRSP) is commonly found on domesticated animals, and becomes infectious when the animals are sick or injured. 

It is an emerging pathogen, can cause sever atopic dermatitis, and can jump between species. 

Researchers screened a library of bacteria which normally live on dogs and cats and grew them in the presence of MRSP, from this identifying a strain of cat bacteria called Staphylococcus felis (S. felis) that was particularly strong at inhibiting MRSP growth. 

It was discovered that this particular strain of S. felis produces multiple antibiotics naturally, which kill MRSP by disrupting its cell wall and increasing the production of toxic free radicals. 

As bacteria can develop resistance to a single antibiotic very easily, S. felis has four genes which code for four distinct antimicrobial peptides, each of which can kill MRSP on their own, but together, make it particularly difficult for the bacteria to fight back. 

After establishing how S. felis kills the MRSP, the researchers tested it out on mice who had been exposed to the most common form of the pathogen. S. felis bacteria was then added to the same site, and the skin showed a reduction in scaling and redness, and there were fewer viable MRSP bacteria left on the skin of those who has been treated with S. felis.

The study is part of a line of work by Professor Richard L. Gallo and his team, working to develop bacteriotherapies for inflammatory skin diseases and skin cancers, and has potential to lead to new bacteriotherapies for both humans and pets. 

Become a member or log in to add this story to your CPD history

VET Festival returns for 2022

News Story 1
 VET Festival, the unique CPD opportunity, is returning for 2022, running from 20 to 21 May.

The outdoor event, held at Loseley Park in Guildford, will feature 17 education streams, with a dedicated stream covering veterinary wellness, leadership and management topics. The festival will feature veterinary speakers from around the world, with the opportunity to collect 14 hours of CPD across the two-day event.

Alongside veterinary education, VET Festival will also offer wellbeing activities such as yoga and mindfulness activities, with the popular VETFest Live Party Night making a return for 2022.

Tickets available here.  

Click here for more...
News Shorts
Avian influenza housing order declared in Yorkshire

A new avian influenza prevention zone has been declared in North Yorkshire following the identification of H5N1 avian influenza at a number of premises.

The requirement means all bird keepers in Harrogate, Hambleton and Richmondshire are now legally required to keep their birds indoors and follow strict biosecurity measures.

Several other cases of H5N1 avian influenza have also been confirmed in recent days at sites in Essex, Cheshire and Cumbria. On Monday (22 November), the disease was identified near Wells-next-the-Sea, North Norfolk.